OUR RESOURCES

New Paradigms in Lung Cancer Management

New Paradigms in Lung Cancer Management 17 February 2022

Welcome & Introduction

Importance of molecular testing in treating Lung cancer

Newer Paradigms in the Treatment of Resected EGFRm Early Lung Cancer

Real world Evidence Osimertinib as SoC in the management of EGFRm NSCLC

Panel Discussion - Managing Early Stage Lung Cancer Patients